#buyrating
NeOnc Technologies continues to gain momentum.
BTIG has initiated coverage with a Buy rating and a $15 PT, led by analyst Thomas Shrader.

A strong vote of confidence as we advance innovative therapies for CNS cancers.

#$NTHI #Biotech #BTIG #BuyRating

investors.neonc.com/static-files...
investors.neonc.com
May 7, 2026 at 9:17 AM
Revisiting: TransDigm: Commercial Exposure Drives Sell-Off, But Valuation Now Attractive #TransDigm #Investing #StockMarket #TDG #BuyRating
TransDigm: Commercial Exposure Drives Sell-Off, But Valuation Now Attractive (NYSE:TDG)
TransDigm shares have declined over 10%, but I maintain a buy rating with a $1,537 price target, implying 32% upside. Click here to read why TDG is a Buy.
dlvr.it
May 1, 2026 at 4:10 PM
Planet Labs: Defense Growth Story Could Still Deliver, But There's A Catch (Upgrade) #PlanetLabs #DefenseStocks #StockMarket #Investment #BuyRating
Planet Labs: Defense Growth Story Could Still Deliver, But There’s A Catch (Upgrade) (PL)
Planet Labs stock is upgraded to a "Buy" amid record Q4 revenue and defense-led growth. Click to learn more about PL's potential upside.
dlvr.it
April 24, 2026 at 5:39 PM
Lithia Gets Citi Buy After April 13 Note: Citi reiterated a Buy on Lithia (LAD) on Apr 13, 2026 (Source: Yahoo Finance); institutional investors should assess used-vehicle margins and acquisition returns before revising… 👈 Read full analysis #Lithia #CitiGroup #BuyRating #Investing #StockMarket
Lithia Gets Citi Buy After April 13 Note
Citi reiterated a Buy on Lithia (LAD) on Apr 13, 2026 (Source: Yahoo Finance); institutional investors should assess used-vehicle margins and acquisition returns before revising allocations.
dlvr.it
April 13, 2026 at 10:58 AM
Freshpet Shares Rise After TD Cowen Upgrade: TD Cowen upgraded Freshpet to Buy on Apr 8, 2026; shares rose about 5% that day as the firm cited improving sales momentum (Investing.com). 👈 Read full analysis #Freshpet #StockMarket #TD_Cowen #Investing #BuyRating
Freshpet Shares Rise After TD Cowen Upgrade
TD Cowen upgraded Freshpet to Buy on Apr 8, 2026; shares rose about 5% that day as the firm cited improving sales momentum (Investing.com).
dlvr.it
April 8, 2026 at 10:50 AM
Kura Sushi Maintained at Buy by DA Davidson Ahead of Q1: DA Davidson kept a Buy on Kura Sushi (KRUS) on Apr 6, 2026; the maintained rating stabilizes expectations ahead of Q1 earnings and points to no anticipated… 👈 Read full analysis #KuraSushi #BuyRating #Investing #StockMarket #EarningsReport
Kura Sushi Maintained at Buy by DA Davidson Ahead of Q1
DA Davidson kept a Buy on Kura Sushi (KRUS) on Apr 6, 2026; the maintained rating stabilizes expectations ahead of Q1 earnings and points to no anticipated material downside (Investing.com).
dlvr.it
April 6, 2026 at 3:38 PM
MP Materials Buy Rating Maintained by BofA at $94: BofA kept a Buy on MP Materials with a $94 target on Apr 1, 2026 (Investing.com); USGS 2024 data shows China produced ~85% of processed rare earths in 2023. 👈 Read full analysis #MPMaterials #BofA #BuyRating #RareEarths #Investing
MP Materials Buy Rating Maintained by BofA at $94
BofA kept a Buy on MP Materials with a $94 target on Apr 1, 2026 (Investing.com); USGS 2024 data shows China produced ~85% of processed rare earths in 2023.
dlvr.it
April 1, 2026 at 11:22 AM
Lithia Motors Buy Rating Reiterated; Q1 Estimate Cut: Benchmark reiterated Buy on Lithia on Mar 30, 2026 and trimmed Q1 estimates by ~3% (Investing.com, 13:55:14 GMT), raising sector-level questions about used-car… 👈 Read full analysis #LithiaMotors #StockMarket #Investing #BuyRating #MarketTrends
Lithia Motors Buy Rating Reiterated; Q1 Estimate Cut
Benchmark reiterated Buy on Lithia on Mar 30, 2026 and trimmed Q1 estimates by ~3% (Investing.com, 13:55:14 GMT), raising sector-level questions about used-car spreads and fixed-ops resilience.
dlvr.it
March 30, 2026 at 2:21 PM
Globe Life Rated Buy at $170 by Texas Capital: Texas Capital initiated Globe Life (GL) with a Buy rating and $170 price target on Mar 28, 2026 (Yahoo Finance); institutional investors should reconcile… 👈 Read full analysis #GlobeLife #TexasCapital #BuyRating #InvestmentStrategies #LifeInsurance
Globe Life Rated Buy at $170 by Texas Capital
Texas Capital initiated Globe Life (GL) with a Buy rating and $170 price target on Mar 28, 2026 (Yahoo Finance); institutional investors should reconcile models to this new research.
dlvr.it
March 29, 2026 at 10:27 AM
Ocular Therapeutix Rated Buy by H.C. Wainwright: H.C. Wainwright reiterated a Buy on Ocular Therapeutix on Mar 27, 2026 (11:37:29 GMT); institutional investors should verify company filings and upcoming… 👈 Read full analysis #OcularTherapeutix #Investing #FinancialNews #StockMarket #BuyRating
Ocular Therapeutix Rated Buy by H.C. Wainwright
H.C. Wainwright reiterated a Buy on Ocular Therapeutix on Mar 27, 2026 (11:37:29 GMT); institutional investors should verify company filings and upcoming catalysts.
dlvr.it
March 27, 2026 at 12:05 PM
PDD Holdings Upgraded to Buy by Nomura: Nomura upgraded PDD to Buy on Mar 27, 2026; Temu (launched Sep 2022) is central to the call and investors should reassess exposure as international monetization is tested. 👈 Read full analysis #PDDHoldings #Nomura #Investment #BuyRating #Temu
PDD Holdings Upgraded to Buy by Nomura
Nomura upgraded PDD to Buy on Mar 27, 2026; Temu (launched Sep 2022) is central to the call and investors should reassess exposure as international monetization is tested.
dlvr.it
March 27, 2026 at 5:49 AM
Revisiting: Rocket Lab: Neutron Setback, Now An Opportunistic Rating Upgrade To Buy #RocketLab #Neutron #Investment #StockMarket #BuyRating
Rocket Lab: Neutron Setback, Now An Opportunistic Rating Upgrade To Buy
Summary Rocket Lab is upgraded to buy, following a sharp price retreat and opportunistic entry point ahead of Q4 earnings. Neutron rocket schedule setbacks persist, with the first launch now likely delayed to late 2026 or early 2027, raising execution risk. Valuation now shows around 3% upside for 2030, with shares still overvalued on near-term earnings but supported by long-term growth positioning. Risks remain for further Neutron delays and cost overruns, but current downside appears limited relative to earlier dilution concerns. Looking for a helping hand in the market? Members of The Aerospace Forum get exclusive ideas and guidance to navigate any climate. Learn More » In January, I downgraded Rocket Lab stock (NASDAQ:RKLB) to sell. Sales-driven valuation methods showed that in the best case the stock was around 20% overvalued. The stock price turned down sharply amidst a broader market More on my IG service If you want full access to all our reports, data and investing ideas, join The Aerospace Forum, the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform. This article was written by Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose goal is to discover investment opportunities in the aerospace, defense and airline industry. With a background in aerospace engineering, he provides analysis of a complex industry with significant growth prospects, and offers context to developments as they occur, describing how they might affect investment theses. His investing ideas are driven by data informed analysis. The investing group also provides direct access to data analytics monitors. Learn more. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
dlvr.it
February 15, 2026 at 1:38 PM
Revisiting: Delta Air Lines: This Overlooked Catalyst Supports My Buy Rating #DeltaAirLines #BuyRating #Investing #StockMarket #Finance
Delta Air Lines: This Overlooked Catalyst Supports My Buy Rating
Summary Delta Air Lines remains a buy with a $85.81 price target, reflecting 24% upside potential and robust EBITDA growth expectations. Q4 2025 results showed margin pressure from higher labor costs, but premium and loyalty revenues continued to outperform the main cabin weakness. DAL expects 2026 margin recovery as industry capacity rationalization and consolidation may restore main cabin revenue growth. Net debt is projected to fall below 1x EBITDA by 2027, supporting future share repurchases and continued dividend increases. Delta Air Lines, Inc. (DAL) gained 21.5% since my October 2025 report, outperforming the S&P 500’s 3.7% gain. The company reported Q4 2025 earnings that beat analyst estimates on revenues but met analyst estimates More on my IG service If you want full access to all our reports, data and investing ideas, join The Aerospace Forum, the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform. This article was written by Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose goal is to discover investment opportunities in the aerospace, defense and airline industry. With a background in aerospace engineering, he provides analysis of a complex industry with significant growth prospects, and offers context to developments as they occur, describing how they might affect investment theses. His investing ideas are driven by data informed analysis. The investing group also provides direct access to data analytics monitors. Learn more. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
dlvr.it
January 21, 2026 at 1:04 PM
Revisiting: Rolls-Royce: Why Lower Valuation Multiples Still Support My Buy Rating #RollsRoyce #Investing #StockMarket #Valuation #BuyRating
Rolls-Royce: Why Lower Valuation Multiples Still Support My Buy Rating
Summary Rolls-Royce retains a Buy rating with a $20.26 price target, reflecting a 16% upside as focus shifts to 2027 earnings. Peer group valuation multiples have contracted, but RYCEY's forward EBITDA and free cash flow estimates have seen modest upward revisions. EBITDA margins are projected to rise from 18.6% in 2025 to 21.6% by 2027, with stable free cash flow conversion around 75%. Shareholder returns are set to increase, exceeding 75% in 2027, supported by strong liquidity and a net cash position. Looking for a helping hand in the market? Members of The Aerospace Forum get exclusive ideas and guidance to navigate any climate. Learn More » Rolls-Royce stock (RYCEF, RYCEY) has advanced 13% since my last report. While the stock did not reach my $18.69, it's a good moment to assess whether the aerospace and defense stock remains attractive, as the price target is governed by More on my IG service If you want full access to all our reports, data and investing ideas, join The Aerospace Forum, the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform. This article was written by Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose goal is to discover investment opportunities in the aerospace, defense and airline industry. With a background in aerospace engineering, he provides analysis of a complex industry with significant growth prospects, and offers context to developments as they occur, describing how they might affect investment theses. His investing ideas are driven by data informed analysis. The investing group also provides direct access to data analytics monitors. Learn more. Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
dlvr.it
January 21, 2026 at 12:46 AM
Hexcel: Why Defense Strength And Aircraft Ramps Still Support A Buy Rating #Hexcel #DefenseIndustry #Aerospace #Investing #BuyRating
Hexcel: Why Defense Strength And Aircraft Ramps Still Support A Buy Rating (NYSE:HXL)
Hexcel Corporation remains attractive, with a maintained buy rating and a 26% upside to a $104.41 price target. Click here to read an analysis of HXL stock now.
dlvr.it
January 20, 2026 at 12:58 PM
🏦 Coinbase earns Buy rating

Goldman Sachs assigned a Buy rating to Coinbase, highlighting the platform’s structural expansion and competitive positioning in the digital asset market.

#Coinbase #GoldmanSachs #BuyRating #Crypto
Coinbase Earns Buy Rating as Goldman Highlights Structural Expansion - Crypto Economy
Goldman Sachs upgraded Coinbase’s rating to “Buy,” anticipating strong growth in cryptocurrency integration with traditional finance.
crypto-economy.com
January 5, 2026 at 6:04 PM
Air Canada: Why I'm Upgrading The Stock To Buy After The Strike #AirCanada #StockMarket #Investing #Finance #BuyRating
Air Canada: Why I’m Upgrading The Stock To Buy After The Strike (OTCMKTS:ACDVF)
Air Canada stock was upgraded to buy with an $18.31 target. Click here to read ACDVF's update on earnings, resilient performance, and future growth.
dlvr.it
November 10, 2025 at 12:35 PM
Revisiting: Hensoldt: Don't Miss Europe's Re-Energized Defense Play #Hensoldt #DefenseStocks #Investing #StockMarket #BuyRating
Hensoldt: Don’t Miss Europe’s Re-Energized Defense Play (OTCMKTS:HAGHY)
Hensoldt’s stock is now a "Buy" with 15% upside, strong order intake, and sector valuation growth. Click here to read an analysis of HAGHY stock now.
dlvr.it
October 31, 2025 at 7:38 PM
UBS initiates “buy” on Sixt SE, sees margins, U.S. market gains driving upside
Investing.com -- UBS has initiated coverage of Sixt SE (ETR:SIXG) with a “buy” rating, citing stronger cost efficiency, improved fleet management and realistic prospects for U.S. market share gains. Shares of the Pullach-headquartered company were up 4% at 04:24 ET (08:24 GMT). The German car rental company, which operates in Europe and North America, reported €4.0 billion in revenue in 2024. UBS projects sales to rise to €4.3 billion in 2025 and €5.5 billion by 2029, representing a 7% compound annual growth rate. Net earnings are forecast to grow from €244 million in 2024 to €325 million in 2025 and €515 million in 2029. Diluted earnings per share are expected to increase from €5.20 in 2024 to €6.93 in 2025 and €10.97 by 2029. UBS analysts said margin recovery is being driven by internal factors. “The margin recovery story is driven by fleet management, instead of the external pricing environment,” the note said. The brokerage expects EBT margins of 11-13% between 2025 and 2027, compared with company guidance of about 10% for 2025 and consensus of 10.2%. The EBIT margin is projected to rise from 12.1% in 2024 to 13.9% in 2025 and 15.7% in 2027. UBS estimates that rental depreciation tailwinds from a refreshed fleet will add 130-250 basis points to margins. Depreciation per unit per month fell below €300 in the second quarter, a trend analysts said supports long-term profitability. “We believe Sixt is now very well positioned to navigate residual value uncertainties regardless of the used car pricing environment,” they said. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. Regional growth is expected to remain uneven. Revenues from Germany, which account for about 30% of the total, are forecast to grow 1-2% annually, while the rest of Europe, representing roughly 40%, is projected to grow 10% annually on strong inbound demand. In North America, which makes up about 30% of sales, revenue is forecast to expand at an 8% annual pace as market share rises from 3% to 5% by 2029. UBS noted that Sixt operates fewer than 10% of the stations of its larger U.S. rivals but generates revenue per station above €10 million annually. Dividend payouts are projected to recover alongside earnings. The dividend per share is expected to rise from €2.70 in 2024 to €3.81 in 2025 and €6.03 in 2029, with a consistent payout ratio of 55%. The dividend yield is forecast to climb from 3.5% in 2024 to 7.4% in 2029. Valuation metrics indicate upside potential. Shares closed at €81.05 on Sept. 3, giving the company a market capitalization of €3.40 billion. UBS set a 12-month price target of €102, saying the stock is trading at 13 times consensus 2025 earnings, at the low end of its historical range of 12x to 19x. The brokerage said, “a re-rating toward the historical average of 16x is likely as margin expansion materialises and gets recognised.” UBS flagged risks including macroeconomic conditions, geopolitical tensions, trade policies, residual value fluctuations and aggressive fleet expansion by competitors. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.
www.investing.com
September 5, 2025 at 8:29 AM
Revisiting: Aegon Stock: 37% Rally Exceeds Targets, P/B Valuation Keeps Buy Rating Alive #Aegon #StockMarket #Investing #Finance #BuyRating
Aegon Stock: 37% Rally Exceeds Targets, P/B Valuation Keeps Buy Rating Alive (NYSE:AEG)
Aegon reports strong H1 results with 19% profit growth and 37% stock surge. Find out more on why I maintain my Buy rating on AEG and if double-digit upside is possible.
dlvr.it
August 29, 2025 at 1:51 PM